VAXXA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8 SEK | +9.59% |
|
+7.38% | -27.27% |
| 04-10 | Vaxxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-23 | Vaxxa AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| Sales 2021 | 1.32M 124K 170K | Sales 2022 | 45.68M 4.28M 5.87M | Capitalization | 12.98M 1.22M 1.67M |
|---|---|---|---|---|---|
| Net income 2021 | -12M -1.12M -1.54M | Net income 2022 | -51M -4.78M -6.56M | EV / Sales 2021 | 14.4 x |
| Net cash position 2021 | 4.69M 439K 603K | Net cash position 2022 | 1.01M 94.12K 129K | EV / Sales 2022 | 0.26 x |
| P/E ratio 2021 |
-1.95
x | P/E ratio 2022 |
-0.25
x | Employees | 5 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | +9.59% | ||
| 1 week | +7.38% | ||
| Current month | -8.57% | ||
| 1 month | -6.43% | ||
| 3 months | -9.09% | ||
| 6 months | -11.11% | ||
| Current year | -27.27% |
1 week
0.68
0.80
1 month
0.681.00
Current year
0.681.30
1 year
0.605.30
3 years
0.6072.70
5 years
0.60195.50
10 years
0.601 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Karl Frindberg
CEO | Chief Executive Officer | 53 | 21-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Per Hägerö
CHM | Chairman | 52 | 15-12-31 |
Milad Pournouri
BRD | Director/Board Member | 30 | - |
Oliver Aleksov
BRD | Director/Board Member | 30 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-29 | 0.8 | +9.59% | 61,053 |
| 24-05-28 | 0.73 | +4.29% | 137,279 |
| 24-05-27 | 0.7 | -4.11% | 36,629 |
| 24-05-24 | 0.73 | -0.68% | 84,540 |
| 24-05-23 | 0.735 | -1.34% | 56,311 |
End-of-day quote NORDIC GROWTH MARKET, May 28, 2024
More quotes- Stock Market
- Equities
- VAXXA Stock
